デフォルト表紙
市場調査レポート
商品コード
1514897

経鼻ワクチン市場：ワクチンタイプ別、デリバリー方法別、流通別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測

Nasal Vaccines Market, By Vaccine Type, By Delivery Method, By Distribution, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 357 Pages
納期
2～3営業日
カスタマイズ可能
経鼻ワクチン市場：ワクチンタイプ別、デリバリー方法別、流通別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測
出版日: 2024年06月11日
発行: AnalystView Market Insights
ページ情報: 英文 357 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

経鼻ワクチン市場規模は2023年に4億1,890万米ドルとなり、2024年から2032年にかけてCAGR 8.56％で拡大

経鼻ワクチン市場-市場力学

呼吸器感染症の有病率の上昇が市場成長を促進

呼吸器感染症の有病率の増加は、経鼻ワクチン市場の成長に拍車をかけています。この技術は、注射針を使わない予防接種の代替手段を提供するためです。世界保健機関（WHO）によると、呼吸器感染症は世界の死亡率の大部分を占めており、インフルエンザだけでも年間29万～65万人が死亡していると推定されています。この負担は、針を使わない予防接種への嗜好の高まりと相まって、経鼻ワクチン市場を牽引しています。例えば、著名な医学雑誌に掲載された最近の研究では、RSV（呼吸器合胞体ウイルス）用の経鼻ワクチンが乳幼児の保護に有効であることが証明され、その可能性が強調されました。呼吸器疾患との戦いが続く中、経鼻ワクチンはより重要な役割を果たすようになると思われます。

経鼻ワクチン市場-主要インサイト

リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約8.56%のCAGRで毎年成長すると推定されます。

ワクチンタイプ別では、弱毒生ワクチンが2023年に最大の市場シェアを示すと予測されています。

デリバリー方法別では、2023年にスプレーが主要なタイプでした。

地域別では、北米が2023年の売上高をリード

経鼻ワクチン市場-セグメンテーション分析：

経鼻ワクチンの世界市場は、ワクチンタイプ、デリバリー方法、流通、地域に基づいてセグメント化されます。

市場はワクチンタイプにより5つに分類される：弱毒生ワクチン,不活化ワクチン,サブユニットワクチン,組換えワクチン,抱合ワクチン.弱毒生ワクチンは、強力な免疫反応を刺激するウイルスの弱毒化ワクチンであり、長期間の免疫持続が期待できることから、大きな成長が見込まれています。しかし、標的免疫反応を引き起こす特定の抗原を含むように設計された組み換えワクチンも、その安全性プロファイルと製造の容易さにより支持を集めています。

市場は送達方法によって2つのカテゴリーに分けられる：スプレー式と滴下式です。点鼻ワクチン市場では、スプレーが支配的な送達方法になると予想されます。スプレーは、特に小児や注射針を嫌う患者にとって投与がより容易であり、最適な免疫反応を得るために鼻腔内により広くワクチンを行き渡らせることができます。

経鼻ワクチン市場-地理的洞察

北米は、確立された研究インフラ、ワクチン開発のための政府資金、新技術の高い採用率により、現在大きなシェアを占めています。しかし、アジア太平洋地域が最速の成長を遂げると予想されています。この背景には、呼吸器系疾患にかかりやすい人口の増加と可処分所得の増加、小児予防接種プログラムを推進する政府の取り組みなどがあります。欧州は、強固な規制の枠組みや先進的なワクチン研究に重点を置き、安定した市場を形成しています。ラテンアメリカと中東・アフリカの新興市場は、公衆衛生インフラの改善と予防接種の効果に対する意識の高まりに重点が置かれているため、有望な可能性を秘めています。各地域の規制要件に対応し、価格面での懸念に対処し、現地のニーズに合わせて送達システムを調整できるメーカーは、この拡大する市場に参入するのに有利な立場にあると思われます。

経鼻ワクチン市場-競合情勢：

アストラゼネカやサノフィ・パスツールのような製薬大手は、ワクチン開発の経験や世界の流通網により、強い存在感を示しています。しかし、中小のバイオテクノロジー企業は、革新的な送達システムや特定の呼吸器疾患をターゲットにしたニッチなワクチンで大きく前進しています。さらに、学術機関や研究センターは、新規経鼻ワクチンプラットフォームの開発において重要な役割を果たしています。これらの企業間の戦略的提携はますます一般的になりつつあり、専門知識を結集して研究開発を加速させています。また、ワクチン・ポートフォリオの拡大や有望な新技術への参入を目指す既存企業の合併・買収も潜在的な要因となっています。このような競合情勢から、成長する経鼻ワクチン市場で足場を築くには、イノベーション、戦略的パートナーシップ、アンメット・メディカル・ニーズへの取り組みに注力する必要があります。

目次

第1章 経鼻ワクチン市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 経鼻ワクチンの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 経鼻ワクチン産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 経鼻ワクチン市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 経鼻ワクチン市場情勢

  • 経鼻ワクチン市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 経鼻ワクチン市場- ワクチンタイプ別

  • 概要
    • ワクチンタイプ別セグメントシェア分析
    • 生弱毒化ワクチン
    • 不活化ワクチン
    • サブユニット
    • 組み換え
    • 結合ワクチン

第8章 経鼻ワクチン市場- デリバリー方法別

  • 概要
    • デリバリー方法別セグメントシェア分析
    • スプレー式
    • 滴下式

第9章 経鼻ワクチン市場- 流通別

  • 概要
    • 流通別セグメントシェア分析
    • 公共
    • プライベート

第10章 経鼻ワクチン市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 経鼻ワクチン業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Altimmune Inc.
    • AstraZeneca PLC
    • Bharat Biotech International Limited
    • BioDiem, Inc.
    • CanSino Biopharmaceuticals Inc.
    • GlaxoSmithKline plc
    • Iovance Biotherapeutics, Inc.
    • Meda Pharma GmbH
    • MeDiVac, Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Seqirus Holdings Pty Ltd
    • Serum Institute of India Pvt. Ltd.
    • TransBio Inc.
    • Vaxlive Inc.
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nasal Vaccines Market: Vaccine Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
  • TABLE Global Nasal Vaccines Market, by Vaccine Type 2019-2032 (USD Million)
  • TABLE Nasal Vaccines Market: Delivery Method Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Delivery Method
  • TABLE Global Nasal Vaccines Market, by Delivery Method 2019-2032 (USD Million)
  • TABLE Nasal Vaccines Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Nasal Vaccines Market, by Distribution 2019-2032 (USD Million)
  • TABLE Nasal Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nasal Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE North America Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE North America Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Europe Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Europe Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE Europe Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Latin America Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Latin America Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE Latin America Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)

List of Figures

  • FIGURE Nasal Vaccines Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Vaccine Type segment market share analysis, 2023 & 2032
  • FIGURE Vaccine Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Delivery Method segment market share analysis, 2023 & 2032
  • FIGURE Delivery Method segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution segment market share analysis, 2023 & 2032
  • FIGURE Distribution segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Nasal Vaccines Market share and leading players, 2023
  • FIGURE Europe Nasal Vaccines Market share and leading players, 2023
  • FIGURE Asia Pacific Nasal Vaccines Market share and leading players, 2023
  • FIGURE Latin America Nasal Vaccines Market share and leading players, 2023
  • FIGURE Middle East and Africa Nasal Vaccines Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Nasal Vaccines Market share analysis by country, 2023
  • FIGURE Germany Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Nasal Vaccines Market share analysis by country, 2023
  • FIGURE India Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Nasal Vaccines Market share analysis by country, 2023
  • FIGURE Brazil Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Nasal Vaccines Market share analysis by country, 2023
  • FIGURE Saudi Arabia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3027

REPORT HIGHLIGHT

Nasal Vaccines Market size was valued at USD 418.9 million in 2023, expanding at a CAGR of 8.56% from 2024 to 2032.

Nasal vaccines, delivered as a spray or mist through the nose, offer a needle-free and potentially more efficient way to trigger immune responses. The growing preference for needle-free vaccinations, particularly among children and needle-phobic individuals. Additionally, nasal vaccines' ability to induce mucosal immunity, potentially providing better protection against respiratory illnesses, fuels market growth. However, challenges like ensuring the stability of the vaccine and navigating stringent regulatory pathways may act as restraints. Exciting opportunities lie in advancements in delivery systems for improved efficacy and the development of vaccines for various respiratory diseases, including COVID-19.

Nasal Vaccines Market- Market Dynamics

Rising prevalence of respiratory infections propelling the market growth

The increasing prevalence of respiratory infections is fueling the growth of the nasal vaccine market, as this technology offers a needle-free alternative to immunization. According to the World Health Organization, respiratory infections account for a significant portion of global mortality, with influenza alone causing an estimated 290,000 to 650,000 deaths annually. This burden, coupled with a growing preference for needle-free vaccinations, is driving the nasal vaccine market. For instance, a recent study published in a reputable medical journal demonstrated that a nasal vaccine for RSV (respiratory syncytial virus) proved effective in protecting infants, highlighting the potential of this. As the fight against respiratory illnesses continues, nasal vaccines are poised to play a more prominent role.

Nasal Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.56% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, Live attenuated vaccines were predicted to show maximum market share in the year 2023

Based on Delivery Method segmentation, Spray was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Nasal Vaccines Market- Segmentation Analysis:

The Global Nasal Vaccines Market is segmented based on Vaccine Type, Delivery Method, Distribution, and Region.

The market is divided into five categories based on Vaccine Type: Live attenuated vaccines, Inactivated vaccines, Subunit, Recombinant, and Conjugate Vaccines. Live attenuated vaccines, weakened versions of the virus that stimulate a strong immune response, are expected to see significant growth due to their potential for long-lasting immunity. However, recombinant vaccines, engineered to contain specific antigens that trigger a targeted immune response, are also gaining traction due to their safety profile and ease of production.

The market is divided into two categories based on the Delivery Method: Spray and Drop. Spray is anticipated to be the dominant delivery method in the nasal vaccine market. Sprays offer greater ease of administration, particularly for children and those with needle aversion, and ensure a wider distribution of the vaccine within the nasal cavity for optimal immune response.

Nasal Vaccines Market- Geographical Insights

North America currently holds a significant share due to established research infrastructure, government funding for vaccine development, and a high adoption rate of new technologies. However, the Asia Pacific region is expected to witness the fastest growth. This is driven by factors like a large and growing population susceptible to respiratory illnesses, rising disposable income, and government initiatives promoting childhood immunization programs. Europe presents a steady market with a focus on robust regulatory frameworks and advanced vaccine research. Emerging markets in Latin America and the Middle East & Africa offer promising potential due to a growing focus on improving public health infrastructure and increasing awareness of vaccination benefits. Manufacturers who can navigate regional regulatory requirements, address affordability concerns, and tailor their delivery systems to suit local needs will be well-positioned to tap into this expanding market.

Nasal Vaccines Market- Competitive Landscape:

Pharmaceutical giants like AstraZeneca and Sanofi Pasteur hold a strong presence due to their experience in vaccine development and global distribution networks. However, smaller biotechnology companies are making significant strides with innovative delivery systems and niche vaccines targeting specific respiratory illnesses. Additionally, academic institutions and research centers play a crucial role in developing novel nasal vaccine platforms. Strategic collaborations between these entities are becoming increasingly common, leveraging combined expertise to accelerate research and development. Mergers and acquisitions are also a potential factor, with established players seeking to expand their vaccine portfolios or gain access to promising new technologies. This competitive landscape necessitates a focus on innovation, strategic partnerships, and a commitment to addressing unmet medical needs to gain a foothold in the growing nasal vaccine market.

Recent Developments:

In January 2023, Bharat Biotech International Limited (BBIL) and Biotechnology Industry Research Assistance (BIRAC) developed iNNCOVACC, the world's first intranasal COVID-19 vaccine to receive approval for the primary 2-dose schedule and as a heterologous booster dose.

In October 2023, Mylab and Serum Institute of India launched Nasovac S4, India's first needle-free nasal influenza vaccine. The vaccine contains four influenza virus strains and is available through healthcare providers and clinics across India, aligning with WHO recommendations

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NASAL VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Altimmune Inc.

AstraZeneca PLC

Bharat Biotech International Limited

BioDiem, Inc.

CanSino Biopharmaceuticals Inc.

GlaxoSmithKline plc

Iovance Biotherapeutics, Inc.

Meda Pharma GmbH

MeDiVac, Inc.

Pfizer Inc.

Sanofi S.A.

Seqirus Holdings Pty Ltd

Serum Institute of India Pvt. Ltd.

TransBio Inc.

Vaxlive Inc.

Others

GLOBAL NASAL VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Live attenuated vaccines
  • Inactivated vaccines
  • Subunit
  • Recombinant
  • Conjugate Vaccines

GLOBAL NASAL VACCINES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Spray
  • Drop

GLOBAL NASAL VACCINES MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Public
  • Private

GLOBAL NASAL VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nasal Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nasal Vaccines Market Snippet by Vaccine Type
    • 2.1.2. Nasal Vaccines Market Snippet by Delivery Method
    • 2.1.3. Nasal Vaccines Market Snippet by Distribution
    • 2.1.4. Nasal Vaccines Market Snippet by Country
    • 2.1.5. Nasal Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. Nasal Vaccines Key Market Trends

  • 3.1. Nasal Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nasal Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nasal Vaccines Market Opportunities
  • 3.4. Nasal Vaccines Market Future Trends

4. Nasal Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nasal Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Nasal Vaccines Market Landscape

  • 6.1. Nasal Vaccines Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nasal Vaccines Market - By Vaccine Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
    • 7.1.2. Live attenuated vaccines
    • 7.1.3. Inactivated vaccines
    • 7.1.4. Subunit
    • 7.1.5. Recombinant
    • 7.1.6. Conjugate Vaccines

8. Nasal Vaccines Market - By Delivery Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
    • 8.1.2. Spray
    • 8.1.3. Drop

9. Nasal Vaccines Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Public
    • 9.1.3. Private

10. Nasal Vaccines Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Nasal Vaccines Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Nasal Vaccines Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Nasal Vaccines Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Nasal Vaccines Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Nasal Vaccines Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Nasal Vaccines Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Altimmune Inc.
    • 11.2.2. AstraZeneca PLC
    • 11.2.3. Bharat Biotech International Limited
    • 11.2.4. BioDiem, Inc.
    • 11.2.5. CanSino Biopharmaceuticals Inc.
    • 11.2.6. GlaxoSmithKline plc
    • 11.2.7. Iovance Biotherapeutics, Inc.
    • 11.2.8. Meda Pharma GmbH
    • 11.2.9. MeDiVac, Inc.
    • 11.2.10. Pfizer Inc.
    • 11.2.11. Sanofi S.A.
    • 11.2.12. Seqirus Holdings Pty Ltd
    • 11.2.13. Serum Institute of India Pvt. Ltd.
    • 11.2.14. TransBio Inc.
    • 11.2.15. Vaxlive Inc.
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us